0400_SHSO_Psychopharmacogenetics_Live

July 9, 2024

Description:

Pharmacogenetics is the study of how an individual's genetic make-up affects one's response to different medications. Knowledge of a patient's genetic profile may help providers determine an appropriate drug or dose. By utilizing PGx, clinicians are guided in personalized prescribing of medications to improve efficacy or prevent side effects.

Target Audience

Nurse, Registered (RN)

Physicians (MD or DO)

Psychologists

Other Healthcare Professionals

Students of Health Professions

Learning Objectives

After completing this course, learners will be able to:

1. Overview of pharmacogenomics (PGx) as a precision medicine approach

• Define basic genomic and phenotypic terminologies.

• Explain general pharmacogenomic concepts.

• Describe basic pharmacogenomic testing methods.

2. Pharmacogenomics (PGx) and its impact in Mental Health’s therapeutic decision-making

• Discuss the rationale for using PGx to optimize medication use.

• Identify key concepts and resources that enable PGx as a decision support tool in prescribing medications.

• Describe the most common pharmacogenes involved in the Mental Health

3. Pharmacogenomics (PGx) resources and methodologies for validation of recommended drug and dosing selection

• Illustrate the process to assess clinical actionability of specific gene-drug pairs using medical evidence.

• Recite the appropriate frameworks to evaluate PGx information.

• Paraphrase the various PGx evidence-based guidelines and resources.

4. Pharmacogenomics (PGx) implementation in clinical settings

• Explain the importance of informatics to support the implementation of PGx in clinical practice through clinical decision support.

• Illustrate the challenges in incorporating PGx in clinical practice.

• Identify strategies for implementing pharmacogenomics in an academic medical center.

• Share lessons learned in implementing PGx program at the US Department of Veterans Affairs

Course summary

Available credit:

1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 ANCC
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This course/program has been awarded 1.00 ANCC contact hour(s). Sutter Health is accredited provider of nursing continuing professional development. Learners should claim only the credit commensurate with the extent of their participation in the activity.
1.00 CA BRN
This activity is approved for 1.00 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Learners should claim only the credit commensurate with the extent of their participation in the activity.
1.00 IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Course opens:

07/09/2024

Course expires:

08/09/2024

Event starts:

07/09/2024 - 12:00pm PDT

Event ends:

07/09/2024 - 1:00pm PDT

Add to calendar:

Rating:

Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:

Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:

Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race

Anderson, A. N., Chan, A. R., & Roman, Y. M. (2022). Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race. Pharmacogenomics, 23(6), 363–370. https://doi.org/10.2217/pgs-2022-0009

Unconscious and Implicit Bias

Panda, G.K., Sahu, I.K., Sahu, D. (2022). Effect of Computation and Cognitive Bias in Healthcare Intelligence and Pharmacogenomics. In: Tripathy, B.K., Lingras, P., Kar, A.K., Chowdhary, C.L. (eds) Next Generation Healthcare Informatics. Studies in Computational Intelligence, vol 1039. Springer, Singapore. https://doi.org/10.1007/978-981-19-2416-3_4

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.

– Provider Designee/Verification: Kerri Maya, MSL, RN

Committee Member(s)